Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
16 oct. 2018 07h47 HE
|
Precipio, Inc.
Fourth consecutive Quarter of Triple-Digit Year-over-Year Quarterly Revenue Growth; Year-to-Date Revenues Increased 163% over First Three Quarters of 2017 NEW HAVEN, Conn., Oct. 16, 2018 (GLOBE...
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results
22 août 2018 21h45 HE
|
Precipio, Inc.
Provides participation details for Thursday, August 23 call NEW HAVEN, Conn., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), wishes to remind...
Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update
17 août 2018 07h37 HE
|
Precipio, Inc.
Conference call with management to be held Thursday August 23, 2018 at 09:00 Eastern Time NEW HAVEN, Conn., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc....
Precipio Appoints New Board Member to Replace Departing Director
09 août 2018 07h37 HE
|
Precipio, Inc.
Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies NEW HAVEN, Conn., Aug. 09, 2018 (GLOBE NEWSWIRE) --...
Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology
19 juin 2018 07h38 HE
|
Precipio, Inc.
Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO),...
Precipio Launches ICE COLD-PCR™ Liquid Biopsy Kit for Pancreatic Cancer
17 mai 2018 07h38 HE
|
Precipio, Inc.
Ultra-sensitive enrichment kit enables development of low cost detection tests, allowing optimized patient treatment NEW HAVEN, Conn., May 17, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology
03 avr. 2018 07h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 03, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that, in response to recent articles, its approach using ICE...
Precipio Restructures Capitalization Table
22 mars 2018 07h37 HE
|
Precipio, Inc.
NEW HAVEN, Conn., March 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), in an 8-K issued today announced an agreement with investors in certain 2017...
Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform
20 mars 2018 07h37 HE
|
Precipio, Inc.
NEW HAVEN, Conn., March 20, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has successfully incorporated the use of High Resolution Melt...
Precipio Settles Lawsuit with Crede Capital
13 mars 2018 08h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has settled its lawsuit with Crede Capital Group LLC,...